XNCR
Xencor Inc
NASDAQ: XNCR · HEALTHCARE · BIOTECHNOLOGY
$11.93
+2.67% today
Updated 2026-04-30
Market cap
$861.36M
P/E ratio
—
P/S ratio
6.86x
EPS (TTM)
$-1.24
Dividend yield
—
52W range
$7 – $19
Volume
0.9M
Xencor Inc (XNCR) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-73.20%
Operating margin
-189.90%
ROE
-14.10%
ROA
-12.10%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2011 | $6.85M | $-11.20M | 100.00% | -138.01% | -163.57% |
| 2012 | $9.52M | $-8.59M | -33.01% | -65.41% | -90.24% |
| 2013 | $10.17M | $-60.26M | -67.13% | -103.42% | -592.39% |
| 2014 | $9.52M | $-16.42M | -94.50% | -172.87% | -172.50% |
| 2015 | $27.76M | $-17.59M | 100.00% | -66.05% | -63.37% |
| 2016 | $87.52M | $23.63M | 100.00% | 25.75% | 26.99% |
| 2017 | $35.71M | $-48.92M | 100.00% | -149.99% | -137.00% |
| 2018 | $40.60M | $-70.41M | 100.00% | -195.48% | -173.41% |
| 2019 | $156.70M | $26.88M | 24.32% | 8.82% | 17.15% |
| 2020 | $122.69M | $-63.54M | 100.00% | -62.59% | -51.79% |
| 2021 | $275.11M | $82.63M | 100.00% | 15.91% | 30.04% |
| 2022 | $164.58M | $-55.18M | 100.00% | -50.11% | -33.53% |
| 2023 | $168.34M | $-126.09M | -50.65% | -82.36% | -74.90% |
| 2024 | $110.49M | $-232.62M | 100.00% | -161.47% | -210.53% |
| 2025 | $125.58M | $-91.92M | 91.63% | -141.35% | -73.20% |